A CRO with expertise in protein production, characterisation and structure

Peak Proteins is delighted to announce Sygnature Discovery’s acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. This acquisition cements Sygnature Discovery as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market leader.

Peak Protein Services

We are a contract research organisation, part of the Sygnature Discovery Group; who provide custom-made, soluble and membrane proteins for use in drug discovery and research applications and X-ray structures of both novel and precedented proteins.

Sygnature Discovery

Our wider organisation, Syngature Discovery provides experienced drug discovery teams, across multiple disciplines to maximise the chances of rapidly reaching your next drug candidate.

Explore what we do

Integrated Drug Discovery Process

Integrated Drug Discovery Process

Chemistry

Chemistry

Bioscience

Bioscience

Computer Aided Drug Design

Computer Aided Drug Design

DMPK

DMPK

In vivo Pharmacology

In vivo Pharmacology

SB Drug Discovery SB Drug Discovery (Ion channels & receptors)

SB Drug Discovery (Ion channels & receptors)

Preclinical and Drug Safety

Preclinical and Drug Safety

Why